Jonathan I Lieber - Net Worth and Insider Trading
Jonathan I Lieber Net Worth
The estimated net worth of Jonathan I Lieber is at least $330 dollars as of 2024-12-26. Jonathan I Lieber is the Director of Salarius Pharmaceuticals Inc and owns about 187 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $271. Jonathan I Lieber is also the CFO of Ocugen Inc and owns about 83 shares of Ocugen Inc (OCGN) stock worth over $59. Details can be seen in Jonathan I Lieber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan I Lieber has not made any transactions after 2022-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan I Lieber
Jonathan I Lieber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan I Lieber owns 6 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Salarius Pharmaceuticals Inc (SLRX) , and Ocugen Inc (OCGN) among others .
Click here to see the complete history of Jonathan I Lieber’s form 4 insider trades.
Insider Ownership Summary of Jonathan I Lieber
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | See Remarks |
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | director |
| OCGN | Ocugen Inc | 2016-12-02 | Chief Financial Officer |
 | | 2012-09-20 | CFO |
| | 2022-08-21 | Chief Financial Officer |
| | 2023-02-01 | See Remarks |
Jonathan I Lieber Latest Holdings Summary
Jonathan I Lieber currently owns a total of 2 stocks. Among these stocks, Jonathan I Lieber owns 187 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 7, 2022, with a value of $271 and a weighting of 82.18%. Jonathan I Lieber also owns 83 shares of Ocugen Inc (OCGN) as of December 2, 2016, with a value of $59 and a weighting of 17.82%.
Latest Holdings of Jonathan I Lieber
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | 187 | 1.45 | 271 |
| OCGN | Ocugen Inc | 2016-12-02 | 83 | 0.71 | 59 |
Holding Weightings of Jonathan I Lieber
Jonathan I Lieber Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 1 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 187 shares on June 7, 2022, which cost Jonathan I Lieber around $7,125.
According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 0 transactions in Ocugen Inc (OCGN) over the past 5 years. The most-recent trade in Ocugen Inc is the acquisition of 83 shares on December 2, 2016, which cost Jonathan I Lieber around $9,750.
Insider Trading History of Jonathan I Lieber
- 1
Jonathan I Lieber Trading Performance
GuruFocus tracks the stock performance after each of Jonathan I Lieber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan I Lieber is -2.46%. GuruFocus also compares Jonathan I Lieber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan I Lieber within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan I Lieber's insider trading performs compared to the benchmark.
Performance of Jonathan I Lieber
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.91 | | | | | |
| Relative Return to S&P 500(%) | 5.94 | | | | | |
Jonathan I Lieber Ownership Network
Jonathan I Lieber Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Jonathan I Lieber is the See Remarks of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Jonathan I Lieber Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan I Lieber. You might contact Jonathan I Lieber via mailing address: C/o Histogenics Corporation, 830 Winter Street #3, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
